Squadron Capital Management LLC
Top Portfolio Positions
33 positions ·
$273,716,290 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
8,474,571 | $58,983,014 | 21.55% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
787,492 | $30,310,567 | 11.07% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
1,300,100 | $26,171,013 | 9.56% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
380,000 | $14,485,600 | 5.29% | |
| ABVX |
Abivax S.A.
Healthcare
|
130,000 | $14,475,500 | 5.29% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
350,000 | $11,025,000 | 4.03% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
4,031,000 | $9,432,540 | 3.45% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
125,000 | $8,993,750 | 3.29% | |
| ANL |
Adlai Nortye Ltd.
Healthcare
|
1,265,231 | $8,755,398 | 3.20% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
822,500 | $8,183,875 | 2.99% |
Portfolio Trend
2 quarters · across all stocks
Holdings in PALI
Shares Held
Position Value (USD)
3 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,250,000 | 3,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,575,000 | 4,500,000 | Shares | Sole | 2026-02-17 | |
| 2025-10-01 | $10,807,500 | 8,250,000 | Shares | Sole | 2025-10-08 | |
| No 13F history on record for this holder in this stock. | ||||||